http://www.zibb.com/healthcare/theme/cq/Corning+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Mon, 21 Sep 2009 12:30:00 GMTMon, 21 Sep 2009 12:30:00 GMT608831http://www.zibb.com/healthcare/theme/cq/Corning+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://finance.yahoo.com/news/Corning-Incorporated-and-bw-60848492.html?x=0&.v=1CORNING, N.Y. & MENLO PARK, Calif.--(BUSINESS WIRE)--Corning Incorporated (NYSE: GLW - News) and Geron Corporation (Nasdaq: GERN - News)http://finance.yahoo.com/news/Corning-Incorporated-and-bw-60848492.html?x=0&.v=1Corning IncorporatedMon, 21 Sep 2009 12:30:00 GMThttp://www.sonosite.com/sonosite/news/2008/05/12/sonosite-appoints-new-cfoBernard J. Pitz named Senior Vice President and CFOMike Schuh to take new position within companyBOTHELL, WA - May 12, 2008 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced that Bernard J. Pitz is joining the company todayhttp://www.sonosite.com/sonosite/news/2008/05/12/sonosite-appoints-new-cfoCorning IncorporatedMon, 12 May 2008 02:15:15 GMThttp://www.dddmag.com/Article-Label-free-optical-biosensors-and-cell-biology.aspxLabel-free optical biosensors can shed new light on cell biology. High throughput and high information screening plays a critical role in drug discovery.http://www.dddmag.com/Article-Label-free-optical-biosensors-and-cell-biology.aspxCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20010104.shtml"We are pleased to add Connetics to our growing list of partners for Flamel Technologies," said Dr. Gerard Soula, chief executive officer of Flamel. "This new partnership is designed to show the application of our proprietary protein and peptide delivery technology to an additional protein.http://www.flamel-technologies.fr/pressReleases/20010104.shtmlCorning Incorporatedhttp://www.corning.com/cn/en/news_center/news_releases/2008/2008080401.aspxCORNING, N.Y., August 04, 2008 – Corning Incorporated (NYSE:GLW) announced today that, through a subsidiary, it signed an agreement to acquire Optimum Manufacturing Corporation for inclusion in its Specialty Materials segment. Located in Charlestown, N.H.http://www.corning.com/cn/en/news_center/news_releases/2008/2008080401.aspxCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20010110.shtmlLyon, France, Jan. 10, 2001 Flamel Technologies (NASDAQ:FLML) has signed two new feasibility study agreements to develop new controlled release dosage forms using Flamel’s Micropump® technology.http://www.flamel-technologies.fr/pressReleases/20010110.shtmlCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20010712.shtmlannounced today that it has signed an agreement with an undisclosed party to work on a new feasibility study employing Medusa®, Flamel's patented nanoparticle technology, containing protein embedded in polyaminoacid polymer.http://www.flamel-technologies.fr/pressReleases/20010712.shtmlCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20010824.shtmlLyon, France, August 24, 2001 - Flamel Technologies (NASDAQ:FLML) announced today the resignation of Jean Deleage as a member of the board of directors of the company. After serving for eleven years as a member of the board, and as an initial venture capital investor in the Company, Mr.http://www.flamel-technologies.fr/pressReleases/20010824.shtmlCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20010927.shtmlThe decision was made by the Agence Francaise de Securitie Sanitaire des Produit de Sante, which made additional requests with regard to the new study.http://www.flamel-technologies.fr/pressReleases/20010927.shtmlCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20011010.shtmlFlamel Technologies (NASDAQ:FLML) announced today that it has signed a licensing agreement with Merck & Co., Inc. (NYSE: MRK) for the application of its Micropump ® technology to an undisclosed class of pharmaceutical compounds. Financial terms of the agreement were not disclosed.http://www.flamel-technologies.fr/pressReleases/20011010.shtmlCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20011023.shtmlFlamel Technologies (NASDAQ:FLML) announced today the completion of a pharmacokinetic human study for a controlled-release formulation of a prominent antibiotic, using Flamel’s proprietary Micropump® technology.http://www.flamel-technologies.fr/pressReleases/20011023.shtmlCorning Incorporatedhttp://www.flamel.com/pressReleases/20020111b.shtmlFlamel Technologies (NASDAQ:FLML) announced today that Novo Nordisk has given notice of the termination of its license agreement with Flamel regarding the development of Basulin®, a long acting form of insulin, effective as of mid- March, 2002http://www.flamel.com/pressReleases/20020111b.shtmlCorning Incorporatedhttp://www.flamel.com/pressReleases/20020111a.shtmlDr. Gerard Soula, president and chief executive officer of Flamel, said "We are delighted to have completed this licensing agreement with Servier, a world class company recognized for its research and development of pharmaceutical entities in multiple therapeutic classes.http://www.flamel.com/pressReleases/20020111a.shtmlCorning Incorporatedhttp://www.flamel.com/pressReleases/20020919.shtmlLyon, France, September 19, 2002 – Flamel Technologies S.A. (NASDAQ: FLML) announced today that it has received a $4 million payment for completion of a further technical milestone in connection with its licensing agreement announced with Servier Monde in January, 2002.http://www.flamel.com/pressReleases/20020919.shtmlCorning Incorporatedhttp://www.flamel.com/pressReleases/20021218.shtmlFlamel Technologies Announces Receipt of $1.5 million Milestone Payment from GlaxoSmithKline for a Sachet Formulation of Controlled Release Augmentinhttp://www.flamel.com/pressReleases/20021218.shtmlCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20030409.shtmlBiovail intends to manufacture this novel form of the well-known and highly prescribed herpes treatment utilizing Flamel's proprietary controlled release "Micropump Technology."http://www.flamel-technologies.fr/pressReleases/20030409.shtmlCorning Incorporatedhttp://www.flamel-technologies.fr/pressReleases/20030804.shtmlLyon, France, August 4, 2003 – Flamel Technologies (Nasdaq:FLML) announced today the results of its extraordinary meeting of shareholders held on July 31, 2003.http://www.flamel-technologies.fr/pressReleases/20030804.shtmlCorning Incorporatedhttp://www.corning.com/news_center/media_resouces/downloads.aspxWorldwide Worldwide | Corning Home | About Us | Products & Services | R & D | Investor Relations | News Center | Careers Overview News Releases In the News Awards & Recognition Corning Stories Media Resources • Company Profile • Business Profiles • Logo Usage • Image Bank • Resource Request •http://www.corning.com/news_center/media_resouces/downloads.aspxCorning Incorporated